Development of chronic venous disease
Authors:
Jiří Spáčil; Jaroslava Svobodová
Authors place of work:
Cévní ordinace, Spamed, Praha
Published in the journal:
Vnitř Lék 2023; 69(E-1): 19-22
Category:
Original Contributions
doi:
https://doi.org/10.36290/vnl.2023.012
Summary
Introduction: Chronic venous disease is known to gradually worsen in the course of years. However, little clinical data is available.
The patient group and methods: We used the set of our patients with completed clinical examination, duplex sonography and photoplethysmography and selected 160 patients examined at our office after 10 and more years. Females represented 79% in the group. The mean age was 54 years (range 18–82 years). Venous varices in lower limbs in the family were reported by 49% patients. Venous sclerotization had been undergone by 6.3% and venous surgery by 10.6% patients. The mean body mass index was 27. We used CEAP classification. The clinical class C1 included 50 patients, C2 included 81, C3 included 15 and C4 included 14 patients. Regurgitation in superficial veins was found in 43%. The mean venous return time after physical activity was 24.5 s.
Results: The last examination was performed after 13 years on average (range 10–28 years). Deterioration of the clinical condition and progression to a higher class were observed in 36% patients in class C1, in 23.5% patients in C2, in 13% patients in C3 and in 7% patients in C4. We did not demonstrate any statistically significant effect of the followed parameters on the progression of the disease.
Conclusion: The progression rate of the disease in our patient group followed at the vascular office for 10 and more years is lower compared to population studies.
Keywords:
progression – chronic venous disease
Zdroje
1. Bobek K, Cajzl L, Čepelák V, et al. Žilní onemocnění a role různých faktorů na jejich vývoj. Čas Lék čes. 1965;104:361-9.
2. Beebe‑Dimmer JL, Pfeifer JR, Ebgle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15:175-84.
3. Criqui MH, Jamosmos M, Froněk A, et al. Chronic venous disease in an ethnically diverse population. The San Diego population study. Am. J. Epidemiol. 2003; 158:448-456.
4. Rabe E, Guex JJ, Puskas A, et al. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein consult program. Int Angiol. 2012;31:105-15.
5. Roztočil K, Piťha J, et al. Nemoci končetinových cév. Maxdorf, 2. vydání, 2021, s. 315-345.
6. De Maeseneer MG, Kakos SK, Aherne T, et al. European society for vascucular Sugery (ESVS) 2022 clinical practice guiedlines on the management of chronic venous disease of the lowerir limbs. Eur J Vasc Endovasc Surg. 2022;63:184-267.
7. Musil D. Co nového přináší aktualizace CEAP klasifikace chronického žilního onemocnění z roku 2020? Vnitr Lek. 2021;67(3):143-1148.
8. Salim S, Machin M, Patterson BO, et al. Global epidemiology of chronic venous disease. Annals of Surgery. 2012;274:971-976.
9. Davies AH. The seriousness of chronic venous disease: A review of real‑world evidence. Adv Ther. 2019;36:S5-S12.
10. Lee AJ, Robertson LA, Boghossian SM, et al. Progression of varicose veins and chronic venous insufficency in the general population in the Edinburgh vein study. J Vasc Surg Venous and Lym, DiS. 2015;3:1826.
11. Labropoulos N, Leon L, Kwon S, et al. Study of the venous reflux progression. J Vasc Surg. 2005;41:291-5.
12. Švejcar J, Přerovský I, Linhart J, Kruml J. Biochemical differences in the composition of primary veins. Am Heart J. 1964;67:572-4.
13. Přerovský I. Patofyziologie žilní cirkulace. In: Fejfar, Z., Přerovský I a spol. Patofyziologie krevního oběhu. Avicenum, Praha, 1980, s. 392-9.
14. Spáčil J, Svobodová J. Má tělesná výška vliv na závažnost chronického žilního onemocnění? Vnitr Lek. 2015;61(3):202-6.
15. Spáčil J. The importace of ambulatory venous hypertension should be revised. Cardiology and Cardiovascular Research. 2019;3:14-17.
16. Vincent JR, Jones GT, Hill GB, vanRij AM. Failure of microvenous valve in small superficial veins is a key to the skin ganges of velus insufficiency. J Vasc Surg. 2011; 54:62S-9S.
17. Lugli M, Longhi M, Guerzoni S, Maleti O. Effect of micronized purified flavonoid fraction treatment on microscopic venous valves reflux in C0S and C1S patiens with chronic venous disease. http://europeanvenous forum.org/wp‑ content/uploads/2021/06/EVF- 2021-Scientific‑Programme‑and‑Book‑of Abstarcts.pdf s. 81.
18. Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014;130(4):33346.
19. Shingler SL, Robertson L, Stewart M. Graduated compression stockings for the initial treatment of varicose veins in people without venous ulceration. Cochrane Database Syst. Rev. 2021;16:7(7).
20. Nicolaides A, Kakkos A, Beakgaard N, et al. Managment of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part I. Int Angio. 2018;37:181-254.
21. Nicolaides A, Kakkos S, Baekgaard N, et al. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part II. Int Angiol. 2020;3 (3):175-240.
22. Zimolová P. Proč je důležité léčbu chronického žilního onemocnění nepřerušovat. Cauasa subita. 2022; 25(2):13-15.
Štítky
Diabetology Endocrinology Internal medicineČlánok vyšiel v časopise
Internal Medicine
2023 Číslo E-1
Najčítanejšie v tomto čísle
- Optimal vascular access to hemodialysis, or what modern medicine offers us
- Development of chronic venous disease
- Ethical aspects in oncology
- Clinical microbiology and its role in current medicine